Showing 1,361 - 1,380 results of 1,447 for search '"liver disease"', query time: 0.07s Refine Results
  1. 1361

    Hepatitis D virus infection triggers CXCL9-11 upregulation in hepatocytes and liver infiltration of CXCR3+ CD4 T cells by Jan-Hendrik Bockmann, Lena Allweiss, Annika Volmari, David da Fonseca Araújo, Matin Kohsar, Anastasia Hyrina, Janine Kah, Zhijuan Song, Josolyn Chan, Katja Giersch, Tassilo Volz, Marc Lütgehetmann, Jeffrey J. Wallin, Dmitry Manuilov, Meghan M. Holdorf, Simon P. Fletcher, Ansgar W. Lohse, Antonio Bertoletti, Julian Schulze zur Wiesch, Maura Dandri

    Published 2025-03-01
    “…Because recruitment of Th1-polarised CD4 T cells to the liver has been also described for other severe liver diseases, such as autoimmune hepatitis, it may represent an important mechanism of aggravating liver diseases. …”
    Get full text
    Article
  2. 1362

    Genetic polymorphism of hepatitis C virus and risk of hepatocellular carcinoma by S. N. Mammayev, A. M. Karimova

    Published 2014-09-01
    “…Hepatocellular carcinoma is one of the most dreadful outcomes of chronic liver diseases, in particular — chronic hepatitis C (CHC). …”
    Get full text
    Article
  3. 1363
  4. 1364

    Effect of Chronic Hepatitis B Virus (HBV) Infection on Lipid Profile in Iraqi Patients by Amnah Raad Ibrahim, Athraa Zaidan Hassan, Raghad Hassan Hussein, Redhwan Abdul Kareem Alameer

    Published 2023-12-01
    “… Hepatitis B Virus (HBV) is known to target the liver, potentially leading to liver diseases. There's a notable link between dyslipidemia, an anomaly in lipid levels, and HBV infection. …”
    Get full text
    Article
  5. 1365
  6. 1366

    Fagonia indica Repairs Hepatic Damage through Expression Regulation of Toll-Like Receptors in a Liver Injury Model by Fareeha Azam, Nadeem Sheikh, Gibran Ali, Asima Tayyeb

    Published 2018-01-01
    “…In conclusion, the current study not only proposes Fagonia indica, a strong hepatoprotective candidate, but also recommends an immune regulatory toll-like receptor pathway as an important therapeutic target in liver diseases.…”
    Get full text
    Article
  7. 1367
  8. 1368

    The effect of economic crisis and austerity measures on deaths of despair in Brazil: An interrupted time series analysis. by Raphael Mendonça Guimarães, Karina Cardoso Meira, Cristiane Teixeira da Silva Vicente, Silvania Suely de Araújo Caribé, Luise Bernardes da Silva Neves, Nicole Almeida Vardiero

    Published 2024-01-01
    “…Some recent analyses have described that, in the context of the instability of social protection institutions and economic crisis, there is an increase in mortality rates selectively from drug overdoses, suicides and alcohol-related liver diseases. This group of causes was named "Deaths of Despair. …”
    Get full text
    Article
  9. 1369

    Osmotic myelinolysis: literature review and case report by G. Rutkauskaitė, A. Klimašauskienė

    Published 2018-03-01
    “…Hyponatremia is commonly found in patients with chronic alcoholism and malnutrition and can be caused by liver diseases, the syndrome of inappropriate antidiuretic hormone secretion, as well as adrenal insufficiency and iatrogenic disorders. …”
    Get full text
    Article
  10. 1370

    Guanidine‐Derived Polymeric Nanoinhibitors Target the Lysosomal V‐ATPase and Activate AMPK Pathway to Ameliorate Liver Lipid Accumulation by Yunfei Zhao, Ke Hu, Fangliang Wang, Lulu Zhao, Yu Su, Jun Chen, Gang Zou, Liming Yang, Li Wei, Mengjiao Deng, Yunyu He, Ping Wang, Xiong Z Ruan, Yaxi Chen, Chao Yu

    Published 2025-01-01
    “…Long‐term and anomalous lipid accumulation in the liver is a highly relevant factor contributing to liver diseases. However, the development of the reliable medications and their pharmacological mechanisms remain insufficient. …”
    Get full text
    Article
  11. 1371

    An Efficient Protocol for Deriving Liver Stem Cells from Neonatal Mice: Validating Its Differentiation Potential by Sugapriya Dhanasekaran, Devilakshmi Sithambaram, Kavitha Govarthanan, Bijesh Kumar Biswal, Rama S. Verma

    Published 2015-01-01
    “…Thus, the unlimited availability of cell type favors setting up the functional recovery of the damaged liver, ensuring ahead success towards treating liver diseases. We attempted to isolate liver stem derived cells (LDSCs) from mouse neonatal liver using single step minimal exposure to enzyme followed by in vitro culturing. …”
    Get full text
    Article
  12. 1372

    Association of Alanine Aminotransferase and Periodontitis: A Cross-Sectional Analysis—NHANES 2009–2012 by R. Constance Wiener, Usha Sambamoorthi, Richard J. Jurevic

    Published 2016-01-01
    “…Alanine Aminotransferase is an enzyme associated with not only liver diseases, liver conditions, and metabolic syndrome, but also inflammation. …”
    Get full text
    Article
  13. 1373

    The role of endoscopic ultrasound in the diagnosis and characterization of focal liver lesions by Ahmed Morad Hashim, Gamal Eldin Mansour Mohamed Gamal, Abeer Abdellatef, Hany Hagag Ahmed

    Published 2024-12-01
    “…Several established diagnostic tools such as magnetic resonance imaging (MRI), transabdominal ultrasound (US), and computed tomography (CT) are well-studied for assessing liver diseases. Endoscopic ultrasound (EUS), traditionally used for evaluating the mediastinum, biliary tract, esophagus, stomach, and pancreas, is increasingly complementing these traditional diagnostic methods in hepatology. …”
    Get full text
    Article
  14. 1374

    Construction and Evaluation of a Subcutaneous Splenic Injection Port for Serial Intraportal Vein Cell Delivery in Murine Disease Models by Toshio Miki, Chika Takano, Irving M. Garcia, Brendan H. Grubbs

    Published 2019-01-01
    “…Liver-directed cell transplantation is, therefore, an attractive therapeutic option to treat various metabolic disorders as well as liver diseases. Although clinical liver-directed cell transplantation requires multiple cell injections into the portal venous system, a mouse model is lacking which allows us to perform repetitive cell injections into the portal venous system. …”
    Get full text
    Article
  15. 1375

    Pathological Microenvironment‐Remodeling Nanoparticles to Alleviate Liver Fibrosis: Reversing Hepatocytes‐Hepatic Stellate Cells Malignant Crosstalk by Ling‐Feng Zhang, Wen‐Qi Deng, Xing‐Huan Wang, Qing‐Wen Huang, Su‐Qing Liang, Ze‐Quan Ding, Liang Qi, Yi Wang, Tian‐Jiao Zhou, Lei Xing, Jai‐Woo Lee, Yu‐Kyoung Oh, Hu‐Lin Jiang

    Published 2025-01-01
    “…This study presents an innovative strategy to modulate cellular interactions for enhanced anti‐fibrotic therapy and suggests a promising approach for treating other chronic liver diseases.…”
    Get full text
    Article
  16. 1376

    Hepatitis C Worldwide and in Brazil: Silent Epidemic—Data on Disease including Incidence, Transmission, Prevention, and Treatment by Iara Fabricia Kretzer, Andrea do Livramento, Joel da Cunha, Sabrina Gonçalves, Iraci Tosin, Celso Spada, Aricio Treitinger

    Published 2014-01-01
    “…The infection is a leading cause of liver diseases like cirrhosis and hepatocellular carcinoma (HCC); thus, HCV infection constitutes a critical public health problem. …”
    Get full text
    Article
  17. 1377
  18. 1378

    Application of dynamic enhanced scanning with GD-EOB-DTPA MRI based on deep learning algorithm for lesion diagnosis in liver cancer patients by Bo Liu, Jinhua Yang, Yifei Wu, Xi Chen, Xueru Wu

    Published 2025-01-01
    “…Gd-EOB-DTPA-enhanced magnetic resonance imaging (MRI) technology is in high demand.ObjectivesThe purpose of the study is to segment the liver using an enhanced multi-gradient deep convolution neural network (EMGDCNN) and to identify and categorize a localized liver lesion using a Gd-EOB-DTPA-enhanced MRI.MethodsWe provided the classifier images of the liver in five states (unenhanced, arterial, portal venous, equilibrium, and hepatobiliary) and labeled them with localized liver diseases (hepatocellular carcinoma, metastasis, hemangiomas, cysts, and scarring). …”
    Get full text
    Article
  19. 1379

    Issues occult hepatitis B virus infection by I. A. Morozov, L. Yu. Ilchenko, N. I. Gromova, I. G. Fyedorov, I. V. Gordeychuk, A. K. Knyazhentseva, E. V. Zverkova, M. I. Mikhaylov

    Published 2012-07-01
    “…With the help of up-to-date molecular-biological and morphological methods to determine frequency of the occult form of chronic hepatitis B (CHB) among HBsAg-negative patients with chronic liver diseases (CLD) of various etiology and to present clinical and morphological characteristic.Material and methods. …”
    Get full text
    Article
  20. 1380

    Intestinal microbiota dysbiosis contributes to the liver damage in subchronic arsenic-exposed mice by Dong Ling, Luo Peng, Zhang Aihua

    Published 2024-10-01
    “…There is an extensive amount of evidence that links changes in the intestinal microbiota structure to the progression and pathophysiology of many liver diseases. However, comprehensive analysis of gut flora dysbiosis in arsenic-induced hepatotoxicity is lacking. …”
    Get full text
    Article